Literature DB >> 21103880

Diffuse postoperative cerebellar swelling in medulloblastoma: report of two cases.

Hideki Ogiwara1, Arthur J Dipatri, Robin M Bowman, Tadanori Tomita, Tord D Alden.   

Abstract

BACKGROUND: We report two cases of diffuse cerebellar swelling with upward transtentorial herniation following medulloblastoma resection. We present our insight for managing medulloblastoma with aggressive clinical behavior. Case 1 is a 32-month-old boy. Magnetic resonance imaging (MRI) revealed fourth ventricular mass with diffuse leptomeningeal metastasis. He underwent gross total resectioning of the tumor and histopathology revealed a large cell medulloblastoma. A ventriculoperitoneal shunt was placed on the 25th postoperative day. Ten days after he developed lethargy, and MRI showed diffuse cerebellar swelling with upward herniation. He underwent emergent posterior fossa decompression; however, he remained unresponsive since then. Case 2 is a 31-month-old boy. MRI revealed a fourth ventricular mass with diffuse leptomeningeal metastasis. He underwent gross total resection and histopathology was a large cell medulloblastoma. Due to developing ventriculomegaly, extraventricular drainage was reinserted on the 11th postoperative day. Four days after, he developed lethargy and decerebrate posturing. MRI showed diffuse cerebellar swelling with upward herniation. He underwent aggressive posterior fossa decompression. Chemotherapy was started postoperatively. Gradually, his movement of extremities improved. On the 79th postoperative day, he started to follow commands and talk some words. He was discharged to a rehabilitation institute and has continued to improve since then.
CONCLUSION: Diffuse cerebellar swelling with upward herniation could occur in patients with aggressive medulloblastoma postoperatively. Our patients had diffuse leptomeningeal dissemination of the tumor at the initial presentation. Close monitoring and prompt diagnosis with earlier surgical posterior fossa decompression and administration of chemotherapy may prevent irreversible neurologic deterioration.

Entities:  

Mesh:

Year:  2010        PMID: 21103880     DOI: 10.1007/s00381-010-1343-3

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  8 in total

1.  "Large cell/anaplastic" medulloblastomas: a Pediatric Oncology Group Study.

Authors:  H G Brown; J L Kepner; E J Perlman; H S Friedman; D R Strother; P K Duffner; L E Kun; P T Goldthwaite; P C Burger
Journal:  J Neuropathol Exp Neurol       Date:  2000-10       Impact factor: 3.685

2.  Outcome for patients with metastatic (M2-3) medulloblastoma treated with SIOP/UKCCSG PNET-3 chemotherapy.

Authors:  Roger E Taylor; Clifford C Bailey; Kathryn J Robinson; Claire L Weston; David A Walker; David Ellison; James Ironside; Barry L Pizer; Linda S Lashford
Journal:  Eur J Cancer       Date:  2005-01-18       Impact factor: 9.162

3.  Risk-adapted craniospinal radiotherapy followed by high-dose chemotherapy and stem-cell rescue in children with newly diagnosed medulloblastoma (St Jude Medulloblastoma-96): long-term results from a prospective, multicentre trial.

Authors:  Amar Gajjar; Murali Chintagumpala; David Ashley; Stewart Kellie; Larry E Kun; Thomas E Merchant; Shaio Woo; Greg Wheeler; Valerie Ahern; Matthew J Krasin; Maryam Fouladi; Alberto Broniscer; Robert Krance; Gregory A Hale; Clinton F Stewart; Robert Dauser; Robert A Sanford; Christine Fuller; Ching Lau; James M Boyett; Dana Wallace; Richard J Gilbertson
Journal:  Lancet Oncol       Date:  2006-10       Impact factor: 41.316

4.  Medulloblastoma: is the 5-year survival rate improving? A review of 80 cases from a single institution.

Authors:  K M David; A T Casey; R D Hayward; W F Harkness; K Phipps; A M Wade
Journal:  J Neurosurg       Date:  1997-01       Impact factor: 5.115

Review 5.  Molecular mechanisms of brain tumor edema.

Authors:  M C Papadopoulos; S Saadoun; D K Binder; G T Manley; S Krishna; A S Verkman
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

6.  Survival rates in patients with primary malignant brain tumors stratified by patient age and tumor histological type: an analysis based on Surveillance, Epidemiology, and End Results (SEER) data, 1973-1991.

Authors:  F G Davis; S Freels; J Grutsch; S Barlas; S Brem
Journal:  J Neurosurg       Date:  1998-01       Impact factor: 5.115

7.  Endothelial cell barrier impairment induced by glioblastomas and transforming growth factor beta2 involves matrix metalloproteinases and tight junction proteins.

Authors:  Hideyuki Ishihara; Hisashi Kubota; Raija L P Lindberg; David Leppert; Sergio M Gloor; Mariella Errede; Daniela Virgintino; Adriano Fontana; Yasuhiro Yonekawa; Karl Frei
Journal:  J Neuropathol Exp Neurol       Date:  2008-05       Impact factor: 3.685

8.  Vascular permeability factor in brain metastases: correlation with vasogenic brain edema and tumor angiogenesis.

Authors:  J Strugar; D Rothbart; W Harrington; G R Criscuolo
Journal:  J Neurosurg       Date:  1994-10       Impact factor: 5.115

  8 in total
  3 in total

1.  An adult multifocal medulloblastoma with diffuse acute postoperative cerebellar swelling: immunohistochemical and molecular genetics analysis.

Authors:  Vladimir Balik; Radek Trojanec; Milena Holzerova; Lucie Tuckova; Igor Sulla; Magdalena Megova; Miroslav Vaverka; Lumir Hrabalek; Jiri Ehrmann
Journal:  Neurosurg Rev       Date:  2014-06-10       Impact factor: 3.042

Review 2.  Delayed diffuse cerebellar swelling after resection of medulloblastoma: case report and review of literature.

Authors:  Ashley L B Raghu; Jothy Kandasamy; Mark Brougham; Pasquale Gallo; Drahus Sokol; Mark A Hughes
Journal:  Childs Nerv Syst       Date:  2017-06-29       Impact factor: 1.475

3.  Anesthetic management of a case of transtentorial upward herniation: An uncommon emergency situation.

Authors:  G Yadav; Rs Sisodia; S Khuba; Ld Mishra
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2012-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.